津药药业
(600488)
| 流通市值：64.42亿 | | | 总市值：64.42亿 |
| 流通股本：10.92亿 | | | 总股本：10.92亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,313,057,171.63 | 608,114,103.87 | 2,908,035,191.99 | 2,231,536,127.33 |
| 营业总成本 | 1,194,468,598.58 | 567,269,140.48 | 2,652,987,006.09 | 2,012,848,166.08 |
| 其他经营收益 | | | | |
| 营业利润 | 67,266,838.72 | 21,910,504.97 | 189,755,227.57 | 196,413,559.12 |
| 利润总额 | 67,327,805.93 | 21,610,397.87 | 122,109,769.75 | 128,169,902.65 |
| 净利润 | 51,406,494.21 | 15,254,425.94 | 122,054,932.22 | 112,297,135.97 |
| 每股收益 | | | | |
| 其他综合收益 | 940,720.35 | -450,224.21 | 17,047,018.45 | 1,112,670.76 |
| 综合收益总额 | 52,347,214.56 | 14,804,201.73 | 139,101,950.67 | 113,409,806.73 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,253,275,829.16 | 2,083,306,683.89 | 2,196,154,236.13 | 1,995,467,697.94 |
| 非流动资产: | | | | |
| 非流动资产合计 | 3,496,209,792.49 | 3,551,296,940.59 | 3,563,537,502.99 | 3,747,672,544.39 |
| 资产总计 | 5,749,485,621.65 | 5,634,603,624.48 | 5,759,691,739.12 | 5,743,140,242.33 |
| 流动负债: | | | | |
| 流动负债合计 | 1,600,334,955.05 | 1,003,640,590.52 | 1,167,248,872.46 | 1,149,193,498.83 |
| 非流动负债: | | | | |
| 非流动负债合计 | 304,721,788.19 | 720,043,828.21 | 697,698,231.91 | 699,621,874.7 |
| 负债合计 | 1,905,056,743.24 | 1,723,684,418.73 | 1,864,947,104.37 | 1,848,815,373.53 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,023,768,744.19 | 3,049,148,585.52 | 3,034,337,129.42 | 3,023,050,596.16 |
| 股东权益合计 | 3,844,428,878.41 | 3,910,919,205.75 | 3,894,744,634.75 | 3,894,324,868.8 |
| 负债和股东权益合计 | 5,749,485,621.65 | 5,634,603,624.48 | 5,759,691,739.12 | 5,743,140,242.33 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,235,336,879.98 | 584,702,709.19 | 2,574,449,481.34 | 1,930,999,463.61 |
| 经营活动现金流出小计 | 1,043,558,577.12 | 596,055,010.8 | 2,437,969,818.38 | 1,897,611,802.65 |
| 经营活动产生的现金流量净额 | 191,778,302.86 | -11,352,301.61 | 136,479,662.96 | 33,387,660.96 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 315,305 | 13,500 | 127,349,138.85 | 8,485,119.85 |
| 投资活动现金流出小计 | 17,712,135.31 | 6,685,345.2 | 76,310,613.05 | 62,708,678.91 |
| 投资活动产生的现金流量净额 | -17,396,830.31 | -6,671,845.2 | 51,038,525.8 | -54,223,559.06 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 100,000,000 | 26,000,000 | 329,129,071.2 | 311,129,071.2 |
| 筹资活动现金流出小计 | 267,128,299.68 | 128,110,253.12 | 315,050,892.82 | 282,533,190.45 |
| 筹资活动产生的现金流量净额 | -167,128,299.68 | -102,110,253.12 | 14,078,178.38 | 28,595,880.75 |
| 汇率变动对现金及现金等价物的影响 | -3,990,465.81 | -1,952,594.27 | 10,064.63 | 1,615,246.07 |
| 现金及现金等价物净增加额 | 3,262,707.06 | -122,086,994.2 | 201,606,431.77 | 9,375,228.72 |
| 期末现金及现金等价物余额 | 799,435,736.46 | 674,086,035.2 | 796,173,029.4 | 603,941,826.35 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 3,262,707.06 | - | 201,606,431.77 | - |